Healthcare & Life Sciences
Intrinsic Therapeutics
series-c-plus
series-c-plus
Stage
2
Investors
About
Intrinsic Therapeutics develops implants designed to reduce the risk of recurrence following discectomy procedures in patients treated for disc herniations.
Explore Intrinsic Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.